SME Support to Evaluate Innovative Medical Technologies: Round 3

Funding opportunity:

SME Support to Evaluate Innovative Medical Technologies: Round 3




Office for Life Sciences (OLS) and Innovate UK

Project total costs (range):

£ 50,000 – £ 250,000



Competition closes:

30/01/2019 (12:00 noon)

The Office for Life Sciences (OLS) will work with Innovate UK, as part of UK Research and Innovation (UKRI), to invest up to £1.5 million in innovation projects. These will be to support developers of innovative medical devices, diagnostics and regulated digital technology to evaluate their product in a real world clinical setting.

You can choose from 2 options:

  • Option 1: Planning and preparation for a study. Project costs can be up to £50,000.
  • Option 2: A study to collect clinical performance and cost-effectiveness data. Project costs can be up to £250,000.

All projects must be business led.

This competition aims to provide support for micro, small and medium-sized enterprises (SMEs). OLS and Innovate UK are looking for studies that aim to develop an evidence base for products that address NHS priorities. The support will allow companies to collect and analyse clinical performance and cost effectiveness data in an NHS setting.

You can work alone or collaborate with others as unfunded partners or sub-contractors. Only the lead partner can claim grant funding.

Your project’s total eligible costs can be up to £50,000 for Option 1 and up to £250,000 for Option 2. Projects must start by 1 July 2019 and be completed by the end of July 2020. They can last between 3 and 12 months.

MSC R&D can help your business develop by supporting you in:
• Identification of appropriate grants and competition calls for proposals
• Partner search for collaborative Research & Innovation
• Bid writing
• Project management
• Audit compliance
• Commercialisation
• Business Planning
• Market Intelligence reports

If you want help with any of these opportunities, please CONTACT us on 0114 230 8401 or email